NYSE · Common Stock · Ophthalmic Goods
78 entities across 41 jurisdictions. Read directly from the company’s own 10-K EX-21 filed 2026-02-18 — see the exhibit.
Which other public companies file entities in the same places:
| Entity | Jurisdiction | Note |
|---|---|---|
| Bausch & Lomb Argentina S.R.L. | Argentina | |
| Waicon Vision S.A. | Argentina | |
| AcuFocus Australia Pty. Ltd. | Australia | |
| Bausch & Lomb (Australia) Pty Ltd | Australia | |
| Bausch & Lomb Australia Holdings Pty Ltd. | Australia | |
| Bausch & Lomb Gesellschaft m.b.H. | Austria | |
| Bausch & Lomb Pharma S.A. | Belgium | |
| BL Indústria Ótica Ltda. | Brazil | |
| Bausch & Lomb (Shanghai) Trading Co., Ltd. | China | |
| Beijing Bausch & Lomb Eyecare Company Ltd | China | |
| Shandong Bausch & Lomb Freda New Packaging Materials Co., Ltd. | China | |
| Shandong Bausch & Lomb Freda Pharmaceutical Co. Ltd. | China | |
| Zhejiang Starview Medical Technology Co., Ltd. | China | |
| Bausch & Lomb France | France | |
| Cutting Edge | France | |
| Laboratoire Chauvin | France | |
| Bausch & Lomb GmbH | Germany | |
| B L E P Holding GmbH | Germany | |
| Dr. Gerhard Mann chem.-pharm. Fabrik GmbH | Germany | |
| Dr. Mann Limited & Co. KG. | Germany | |
| Dr. Robert Winzer Pharma GmbH | Germany | |
| ELIOS Vision GmbH | Germany | |
| Grundstückverwaltungsgesellschaft Dr. G.M. chem.-pharm. Fabrik GmbH | Germany | |
| Technolas Perfect Vision GmbH | Germany | |
| Bausch Health Hellas Single-Member Pharmaceuticals Société Anonyme (aka Bausch Health Hellas) | Greece | |
| Bausch & Lomb (Hong Kong) Limited | Hong Kong | |
| Sino Concept Technology Limited | Hong Kong | |
| Bausch & Lomb India Private Limited | India | |
| PT Bausch Lomb Indonesia | Indonesia | |
| Bausch + Lomb Ireland Limited | Ireland | |
| Bausch & Lomb-IOM S.P.A. | Italy | |
| B.L.J. Company Limited | Japan | |
| Bausch & Lomb Korea Co. Ltd. | Korea | |
| Bausch Health Korea Co., Ltd. | Korea | |
| Bescon Co., Ltd. | Korea | |
| Bausch & Lomb (Malaysia) Sdn. Bhd. | Malaysia | |
| Bausch & Lomb México Holdings, S.A. de C.V. | Mexico | |
| Bausch+Lomb Netherlands B.V. | Netherlands | |
| Bausch & Lomb (New Zealand) Limited | New Zealand | |
| Bausch Health Peru, S.R.L. | Peru | |
| Bausch & Lomb Philippines Inc. | Philippines | |
| Bausch & Lomb Poland Spółka z ograniczoną odpowiedzialnością (aka Bausch & Lomb Poland sp. z o.o.) | Poland | |
| Valeant Med Spółka z ograniczoną odpowiedzialnością (aka Valeant Med sp z.o.o.) | Poland | |
| Bausch Health Romania S.R.L. | Romania | |
| Bausch and Lomb Arabia Regional Headquarters | Saudi Arabia | |
| Bausch & Lomb (Singapore) Private Limited | Singapore | |
| Bausch & Lomb (South Africa) Pty Limited | South Africa | |
| Soflens (Proprietary) Limited | South Africa | |
| Bausch & Lomb S.A. | Spain | |
| Cutting Edge Surgical España | Spain | |
| Servicio Integral De Esterilización, S.L.U. | Spain | |
| Servicio Integral Hospitalario, S.L.U. | Spain | |
| Bausch & Lomb Nordic AB | Sweden | |
| Bausch & Lomb Swiss AG | Switzerland | |
| Bausch & Lomb Taiwan Limited | Taiwan | |
| Bausch & Lomb (Thailand) Limited | Thailand | |
| Bausch & Lomb Sağlik ve Optik Ürünleri Ticaret A.Ş. | Turkey | |
| “Bausch Health” Limited Liability Company (aka “Bausch Health” LLC) | Ukraine | |
| Bausch Health Trading DWC - LLC | United Arab Emirates | |
| Bausch & Lomb U.K. Limited | United Kingdom | |
| Kestrel Ophthalmics Ltd. | United Kingdom | |
| Sterimedix Limited | United Kingdom | |
| AcuFocus Holdings, Inc. | Delaware | |
| AcuFocus, Inc. | Delaware | |
| Audrey Enterprise, LLC | Delaware | |
| Bausch Foundation, LLC | Delaware | |
| Bausch & Lomb Americas Inc. | Delaware | |
| Bausch & Lomb Financing LLC | Delaware | |
| Elios Vision, Inc. | Delaware | |
| Kedalion Therapeutics, Inc. | Delaware | |
| Synergetics IP, Inc. | Delaware | |
| TearLab Corporation (d/b/a Trukera Medical) | Delaware | |
| TearLab Research, Inc. (d/b/a Trukera Medical) | Delaware | |
| Whitecap Biosciences LLC | Delaware | |
| Total Titanium, Inc. | Illinois | |
| Synergetics, Inc. | Missouri | |
| Paragon BioTeck, Inc. | Nevada | |
| Alden Optical Laboratories, Inc. | New York |
Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.
| Year | Revenue | Net income | Free cash flow | Gross margin | Shares |
|---|---|---|---|---|---|
| FY2020 | $3.4B | −$18.0M | $269.0M | — | 350,000,000 |
| FY2021 | $3.8B | $182.0M | $680.0M | — | 350,000,000 |
| FY2022 | $3.8B | $6.0M | $170.0M | — | 350,200,000 |
| FY2023 | $4.1B | −$260.0M | −$198.0M | — | 350,500,000 |
| FY2024 | $4.8B | −$317.0M | −$59.0M | — | 351,800,000 |
| FY2025 | $5.1B | −$360.0M | −$66.0M | — | 353,800,000 |
Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.
Bausch & Lomb Corp files under SIC 3851 — all 3 ophthalmic goods companies compared on assets and F-score.
The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.
Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.
